Asterias Biotherapeutics, Inc. was a big mover last session, as the company saw its shares rise nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company since Aug 29, as the stock is now up over 42%.

None of the estimates for this stock were revised over the past seven days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Friday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Asterias Biotherapeutics currently carries a Zacks Rank #2 (Buy), while its Earnings ESP is positive.

ASTERIAS BIOTHR Price

 

ASTERIAS BIOTHR Price | ASTERIAS BIOTHR Quote

A better-ranked stock in the same industry is ANI Pharmaceuticals, Inc. (ANIP Quick QuoteANIP - Free Report) , sporting a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here.

Is AST going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>